These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 29125580)

  • 1. Structural Diversity, Biological Properties and Applications of Natural Products from Cyanobacteria. A Review.
    Shah SAA; Akhter N; Auckloo BN; Khan I; Lu Y; Wang K; Wu B; Guo YW
    Mar Drugs; 2017 Nov; 15(11):. PubMed ID: 29125580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive natural products from marine cyanobacteria for drug discovery.
    Tan LT
    Phytochemistry; 2007 Apr; 68(7):954-79. PubMed ID: 17336349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are There Any Other Compounds Isolated From Dermacoccus spp at All?
    AlMatar M; Eldeeb M; Makky EA; Köksal F; Var I; Kayar B
    Curr Microbiol; 2017 Jan; 74(1):132-144. PubMed ID: 27785553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical and bioactive diversities of the genus Chaetomium secondary metabolites.
    Zhang Q; Li HQ; Zong SC; Gao JM; Zhang AL
    Mini Rev Med Chem; 2012 Feb; 12(2):127-48. PubMed ID: 22372603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary Metabolites from Marine Micromonospora: Chemistry and Bioactivities.
    Qi S; Gui M; Li H; Yu C; Li H; Zeng Z; Sun P
    Chem Biodivers; 2020 Apr; 17(4):e2000024. PubMed ID: 32100940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of unusual aminocyclitol-containing natural products.
    Mahmud T; Flatt PM; Wu X
    J Nat Prod; 2007 Aug; 70(8):1384-91. PubMed ID: 17661520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dereplication of Natural Products with Antimicrobial and Anticancer Activity from Brazilian Cyanobacteria.
    Shishido TK; Popin RV; Jokela J; Wahlsten M; Fiore MF; Fewer DP; Herfindal L; Sivonen K
    Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31878347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal Purposes: Bioactive Metabolites from Marine-derived Organisms.
    Li T; Ding T; Li J
    Mini Rev Med Chem; 2019; 19(2):138-164. PubMed ID: 28969543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytoplankton of the Curonian Lagoon as a New Interesting Source for Bioactive Natural Products. Special Impact on Cyanobacterial Metabolites.
    Overlingė D; Toruńska-Sitarz A; Cegłowska M; Błaszczyk A; Szubert K; Pilkaitytė R; Mazur-Marzec H
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marine Actinomycetes-derived Natural Products.
    Yang C; Qian R; Xu Y; Yi J; Gu Y; Liu X; Yu H; Jiao B; Lu X; Zhang W
    Curr Top Med Chem; 2019; 19(31):2868-2918. PubMed ID: 31724505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive Secondary Metabolites from a Thai Collection of Soil and Marine-Derived Fungi of the Genera Neosartorya and Aspergillus.
    Zin WW; Prompanya C; Buttachon S; Kijjoa A
    Curr Drug Deliv; 2016; 13(3):378-88. PubMed ID: 26935258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past Decade.
    Mi Y; Zhang J; He S; Yan X
    Mar Drugs; 2017 May; 15(5):. PubMed ID: 28475149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.
    Tan LT; Phyo MY
    Molecules; 2020 May; 25(9):. PubMed ID: 32397127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Diversity and Biological Activities of Novel Secondary Metabolites from Endophytes.
    Gao H; Li G; Lou HX
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29534010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Products from Cyanobacteria: Focus on Beneficial Activities.
    Demay J; Bernard C; Reinhardt A; Marie B
    Mar Drugs; 2019 May; 17(6):. PubMed ID: 31151260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immense essence of excellence: marine microbial bioactive compounds.
    Bhatnagar I; Kim SK
    Mar Drugs; 2010 Oct; 8(10):2673-701. PubMed ID: 21116414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioprospecting microalgae and cyanobacteria for biopharmaceutical applications.
    Saeed MU; Hussain N; Shahbaz A; Hameed T; Iqbal HMN; Bilal M
    J Basic Microbiol; 2022 Sep; 62(9):1110-1124. PubMed ID: 34914840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carriebowlinol, an antimicrobial tetrahydroquinolinol from an assemblage of marine cyanobacteria containing a novel taxon.
    Soares AR; Engene N; Gunasekera SP; Sneed JM; Paul VJ
    J Nat Prod; 2015 Mar; 78(3):534-8. PubMed ID: 25536090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological targets and mechanisms of action of natural products from marine cyanobacteria.
    Salvador-Reyes LA; Luesch H
    Nat Prod Rep; 2015 Mar; 32(3):478-503. PubMed ID: 25571978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in chemistry and bioactivity of marine cyanobacteria Moorea species.
    Xu J; Zhang T; Yao J; Lu J; Liu Z; Ding L
    Eur J Med Chem; 2020 Sep; 201():112473. PubMed ID: 32652435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.